The medications can reduce or eliminate weight-related complications in children but are in short supply, and insurers are denying coverage, said pediatricians.
Researchers report an independent inverse link between time spent within a target body weight range and composite kidney outcomes in individuals with overweight/obesity and type 2 diabetes.
New research shows use of the drugs in pregnancy is on the rise, particularly in the United States, and although teratogenic risks appear low, limitations are notable.